Indian facilities of Quest Diagnostics acquired by Oncquest Labs
New Delhi: Diagnostics chain Oncquest Laboratories on Monday said it has acquired Indian facilities of Quest Diagnostics, from clinical research and diagnostics company Strand Life Sciences.
The company, however, did not provide any financial details of the acquisition.
Strand Life Sciences had acquired the India medical diagnostics business of Quest Diagnostics in 2018.
Read also:COVID-19: Quest Diagnostics eyes test speed at 'acceptable' level by September
"This acquisition is just the right trigger we needed to catapult our growth plans. We do look forward to many more such synergistic acquisitions to help us ramp-up our operations in India," Oncquest Laboratories Promoter & MD Aditya Burman said. Oncquest Laboratories Director Ravi Gaur said, "The acquisition will help in making it (Oncquest Laboratories), the future epicentre of the much technological advancement in healthcare".
Read also: Sanofi to begin tender offer to acquire Principia Biopharma
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.